nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Epirubicin—stomach cancer	0.44	0.653	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—stomach cancer	0.234	0.347	CbGbCtD
Moxifloxacin—TOP2A—Topotecan—Irinotecan—stomach cancer	0.00201	0.279	CbGdCrCtD
Moxifloxacin—TOP2A—Paclitaxel—Docetaxel—stomach cancer	0.00141	0.196	CbGdCrCtD
Moxifloxacin—TOP2A—Cladribine—Floxuridine—stomach cancer	0.00105	0.146	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—stomach cancer	0.000473	0.0656	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—stomach cancer	0.000473	0.0656	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—stomach cancer	0.000473	0.0656	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—stomach cancer	0.000437	0.0607	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—stomach cancer	0.000437	0.0607	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—stomach cancer	0.000437	0.0607	CbGdCrCtD
Moxifloxacin—Gatifloxacin—ALB—stomach cancer	0.000397	0.512	CrCbGaD
Moxifloxacin—Norfloxacin—CYP2A6—stomach cancer	0.000379	0.489	CrCbGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RBP1—stomach cancer	0.000116	0.0585	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—ID4—stomach cancer	0.000108	0.0547	CbGpPWpGaD
Moxifloxacin—Hepatitis—Doxorubicin—stomach cancer	9.4e-05	0.000297	CcSEcCtD
Moxifloxacin—Insomnia—Capecitabine—stomach cancer	9.37e-05	0.000296	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—stomach cancer	9.36e-05	0.000296	CcSEcCtD
Moxifloxacin—Rash—Fluorouracil—stomach cancer	9.35e-05	0.000295	CcSEcCtD
Moxifloxacin—Dermatitis—Fluorouracil—stomach cancer	9.34e-05	0.000295	CcSEcCtD
Moxifloxacin—Pharyngitis—Doxorubicin—stomach cancer	9.33e-05	0.000295	CcSEcCtD
Moxifloxacin—Paraesthesia—Capecitabine—stomach cancer	9.31e-05	0.000294	CcSEcCtD
Moxifloxacin—Decreased appetite—Docetaxel—stomach cancer	9.31e-05	0.000294	CcSEcCtD
Moxifloxacin—Headache—Fluorouracil—stomach cancer	9.29e-05	0.000294	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—stomach cancer	9.29e-05	0.000293	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—stomach cancer	9.26e-05	0.000293	CcSEcCtD
Moxifloxacin—Dysgeusia—Methotrexate—stomach cancer	9.26e-05	0.000292	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Docetaxel—stomach cancer	9.24e-05	0.000292	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—stomach cancer	9.24e-05	0.000292	CcSEcCtD
Moxifloxacin—Dyspnoea—Capecitabine—stomach cancer	9.24e-05	0.000292	CcSEcCtD
Moxifloxacin—Fatigue—Docetaxel—stomach cancer	9.23e-05	0.000292	CcSEcCtD
Moxifloxacin—Angiopathy—Epirubicin—stomach cancer	9.22e-05	0.000291	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—stomach cancer	9.22e-05	0.000291	CcSEcCtD
Moxifloxacin—Nausea—Irinotecan—stomach cancer	9.2e-05	0.000291	CcSEcCtD
Moxifloxacin—Immune system disorder—Epirubicin—stomach cancer	9.18e-05	0.00029	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Epirubicin—stomach cancer	9.16e-05	0.000289	CcSEcCtD
Moxifloxacin—Constipation—Docetaxel—stomach cancer	9.15e-05	0.000289	CcSEcCtD
Moxifloxacin—Pain—Docetaxel—stomach cancer	9.15e-05	0.000289	CcSEcCtD
Moxifloxacin—Back pain—Methotrexate—stomach cancer	9.14e-05	0.000289	CcSEcCtD
Moxifloxacin—Dyspepsia—Capecitabine—stomach cancer	9.12e-05	0.000288	CcSEcCtD
Moxifloxacin—Chills—Epirubicin—stomach cancer	9.12e-05	0.000288	CcSEcCtD
Moxifloxacin—Arrhythmia—Epirubicin—stomach cancer	9.08e-05	0.000287	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—stomach cancer	9.06e-05	0.000286	CcSEcCtD
Moxifloxacin—Decreased appetite—Capecitabine—stomach cancer	9.01e-05	0.000285	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Capecitabine—stomach cancer	8.95e-05	0.000283	CcSEcCtD
Moxifloxacin—Fatigue—Capecitabine—stomach cancer	8.94e-05	0.000282	CcSEcCtD
Moxifloxacin—Vision blurred—Methotrexate—stomach cancer	8.91e-05	0.000281	CcSEcCtD
Moxifloxacin—Mental disorder—Epirubicin—stomach cancer	8.9e-05	0.000281	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—stomach cancer	8.89e-05	0.000281	CcSEcCtD
Moxifloxacin—Constipation—Capecitabine—stomach cancer	8.86e-05	0.00028	CcSEcCtD
Moxifloxacin—Pain—Capecitabine—stomach cancer	8.86e-05	0.00028	CcSEcCtD
Moxifloxacin—Malnutrition—Epirubicin—stomach cancer	8.85e-05	0.00028	CcSEcCtD
Moxifloxacin—Erythema—Epirubicin—stomach cancer	8.85e-05	0.00028	CcSEcCtD
Moxifloxacin—Feeling abnormal—Docetaxel—stomach cancer	8.82e-05	0.000279	CcSEcCtD
Moxifloxacin—Nausea—Fluorouracil—stomach cancer	8.81e-05	0.000278	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—stomach cancer	8.79e-05	0.000278	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Methotrexate—stomach cancer	8.77e-05	0.000277	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—stomach cancer	8.77e-05	0.000277	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Docetaxel—stomach cancer	8.75e-05	0.000277	CcSEcCtD
Moxifloxacin—Anaemia—Methotrexate—stomach cancer	8.74e-05	0.000276	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—stomach cancer	8.73e-05	0.000276	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—stomach cancer	8.72e-05	0.000275	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—stomach cancer	8.68e-05	0.000274	CcSEcCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—stomach cancer	8.67e-05	0.0437	CbGpPWpGaD
Moxifloxacin—Dysgeusia—Epirubicin—stomach cancer	8.66e-05	0.000274	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—stomach cancer	8.59e-05	0.000271	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—stomach cancer	8.56e-05	0.00027	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYT1—stomach cancer	8.56e-05	0.0432	CbGpPWpGaD
Moxifloxacin—Feeling abnormal—Capecitabine—stomach cancer	8.54e-05	0.00027	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—stomach cancer	8.53e-05	0.00027	CcSEcCtD
Moxifloxacin—Malaise—Methotrexate—stomach cancer	8.53e-05	0.000269	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—stomach cancer	8.51e-05	0.000269	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—stomach cancer	8.49e-05	0.000268	CcSEcCtD
Moxifloxacin—Vertigo—Methotrexate—stomach cancer	8.49e-05	0.000268	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Capecitabine—stomach cancer	8.47e-05	0.000268	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—stomach cancer	8.47e-05	0.000268	CcSEcCtD
Moxifloxacin—Abdominal pain—Docetaxel—stomach cancer	8.46e-05	0.000267	CcSEcCtD
Moxifloxacin—Body temperature increased—Docetaxel—stomach cancer	8.46e-05	0.000267	CcSEcCtD
Moxifloxacin—Leukopenia—Methotrexate—stomach cancer	8.46e-05	0.000267	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—stomach cancer	8.44e-05	0.000267	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—stomach cancer	8.4e-05	0.000265	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—stomach cancer	8.34e-05	0.000263	CcSEcCtD
Moxifloxacin—Cough—Methotrexate—stomach cancer	8.25e-05	0.000261	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—stomach cancer	8.24e-05	0.00026	CcSEcCtD
Moxifloxacin—Urticaria—Capecitabine—stomach cancer	8.23e-05	0.00026	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Epirubicin—stomach cancer	8.21e-05	0.000259	CcSEcCtD
Moxifloxacin—Body temperature increased—Capecitabine—stomach cancer	8.19e-05	0.000259	CcSEcCtD
Moxifloxacin—Abdominal pain—Capecitabine—stomach cancer	8.19e-05	0.000259	CcSEcCtD
Moxifloxacin—Convulsion—Methotrexate—stomach cancer	8.19e-05	0.000259	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—stomach cancer	8.19e-05	0.000259	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—stomach cancer	8.19e-05	0.000259	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—stomach cancer	8.18e-05	0.000258	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—stomach cancer	8.13e-05	0.000257	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—stomach cancer	8.07e-05	0.000255	CcSEcCtD
Moxifloxacin—Arthralgia—Methotrexate—stomach cancer	8.05e-05	0.000254	CcSEcCtD
Moxifloxacin—Chest pain—Methotrexate—stomach cancer	8.05e-05	0.000254	CcSEcCtD
Moxifloxacin—Myalgia—Methotrexate—stomach cancer	8.05e-05	0.000254	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—stomach cancer	8.03e-05	0.000254	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—stomach cancer	8.02e-05	0.000253	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	7.99e-05	0.000253	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—stomach cancer	7.98e-05	0.000252	CcSEcCtD
Moxifloxacin—Discomfort—Methotrexate—stomach cancer	7.95e-05	0.000251	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—stomach cancer	7.95e-05	0.000251	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—stomach cancer	7.95e-05	0.000251	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—stomach cancer	7.93e-05	0.000251	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—stomach cancer	7.92e-05	0.00025	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—stomach cancer	7.92e-05	0.00025	CcSEcCtD
Moxifloxacin—Hypersensitivity—Docetaxel—stomach cancer	7.89e-05	0.000249	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—stomach cancer	7.87e-05	0.000249	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2D—stomach cancer	7.83e-05	0.0395	CbGpPWpGaD
Moxifloxacin—Palpitations—Epirubicin—stomach cancer	7.82e-05	0.000247	CcSEcCtD
Moxifloxacin—Confusional state—Methotrexate—stomach cancer	7.78e-05	0.000246	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—stomach cancer	7.78e-05	0.000246	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—stomach cancer	7.72e-05	0.000244	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Methotrexate—stomach cancer	7.72e-05	0.000244	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—stomach cancer	7.71e-05	0.000244	CcSEcCtD
Moxifloxacin—Asthenia—Docetaxel—stomach cancer	7.68e-05	0.000243	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—stomach cancer	7.67e-05	0.000242	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—stomach cancer	7.64e-05	0.000241	CcSEcCtD
Moxifloxacin—Hypersensitivity—Capecitabine—stomach cancer	7.64e-05	0.000241	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—stomach cancer	7.6e-05	0.00024	CcSEcCtD
Moxifloxacin—Pruritus—Docetaxel—stomach cancer	7.57e-05	0.000239	CcSEcCtD
Moxifloxacin—Nervous system disorder—Methotrexate—stomach cancer	7.57e-05	0.000239	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—stomach cancer	7.57e-05	0.000239	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Methotrexate—stomach cancer	7.55e-05	0.000239	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—stomach cancer	7.53e-05	0.000238	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—stomach cancer	7.53e-05	0.000238	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—stomach cancer	7.53e-05	0.000238	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—stomach cancer	7.52e-05	0.000238	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—stomach cancer	7.51e-05	0.000237	CcSEcCtD
Moxifloxacin—Skin disorder—Methotrexate—stomach cancer	7.49e-05	0.000237	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	7.48e-05	0.000236	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Methotrexate—stomach cancer	7.46e-05	0.000236	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—stomach cancer	7.44e-05	0.000235	CcSEcCtD
Moxifloxacin—Asthenia—Capecitabine—stomach cancer	7.44e-05	0.000235	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—stomach cancer	7.38e-05	0.000233	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—stomach cancer	7.37e-05	0.000233	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—stomach cancer	7.35e-05	0.000232	CcSEcCtD
Moxifloxacin—Anorexia—Methotrexate—stomach cancer	7.35e-05	0.000232	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—stomach cancer	7.34e-05	0.000232	CcSEcCtD
Moxifloxacin—Pruritus—Capecitabine—stomach cancer	7.33e-05	0.000232	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—stomach cancer	7.33e-05	0.000232	CcSEcCtD
Moxifloxacin—Diarrhoea—Docetaxel—stomach cancer	7.32e-05	0.000231	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—stomach cancer	7.28e-05	0.00023	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—stomach cancer	7.23e-05	0.000229	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—stomach cancer	7.22e-05	0.000228	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—stomach cancer	7.22e-05	0.000228	CcSEcCtD
Moxifloxacin—Hypotension—Methotrexate—stomach cancer	7.21e-05	0.000228	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—stomach cancer	7.19e-05	0.000227	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—stomach cancer	7.14e-05	0.000226	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—stomach cancer	7.1e-05	0.000224	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—stomach cancer	7.09e-05	0.000224	CcSEcCtD
Moxifloxacin—Diarrhoea—Capecitabine—stomach cancer	7.09e-05	0.000224	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—stomach cancer	7.08e-05	0.000224	CcSEcCtD
Moxifloxacin—Dizziness—Docetaxel—stomach cancer	7.08e-05	0.000224	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—stomach cancer	7.07e-05	0.000223	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—stomach cancer	7.07e-05	0.000223	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—stomach cancer	7.05e-05	0.000223	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.03e-05	0.000222	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—stomach cancer	7.01e-05	0.000222	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Epirubicin—stomach cancer	6.98e-05	0.000221	CcSEcCtD
Moxifloxacin—Insomnia—Methotrexate—stomach cancer	6.98e-05	0.00022	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—stomach cancer	6.97e-05	0.00022	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—stomach cancer	6.97e-05	0.00022	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—stomach cancer	6.97e-05	0.00022	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—stomach cancer	6.94e-05	0.000219	CcSEcCtD
Moxifloxacin—Paraesthesia—Methotrexate—stomach cancer	6.93e-05	0.000219	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	6.92e-05	0.000219	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—stomach cancer	6.89e-05	0.000218	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—stomach cancer	6.88e-05	0.000217	CcSEcCtD
Moxifloxacin—Dyspnoea—Methotrexate—stomach cancer	6.88e-05	0.000217	CcSEcCtD
Moxifloxacin—Somnolence—Methotrexate—stomach cancer	6.86e-05	0.000217	CcSEcCtD
Moxifloxacin—Dizziness—Capecitabine—stomach cancer	6.85e-05	0.000217	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—stomach cancer	6.82e-05	0.000215	CcSEcCtD
Moxifloxacin—Vomiting—Docetaxel—stomach cancer	6.81e-05	0.000215	CcSEcCtD
Moxifloxacin—Dyspepsia—Methotrexate—stomach cancer	6.79e-05	0.000215	CcSEcCtD
Moxifloxacin—Rash—Docetaxel—stomach cancer	6.75e-05	0.000213	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—stomach cancer	6.75e-05	0.000213	CcSEcCtD
Moxifloxacin—Dermatitis—Docetaxel—stomach cancer	6.74e-05	0.000213	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—stomach cancer	6.74e-05	0.000213	CcSEcCtD
Moxifloxacin—Decreased appetite—Methotrexate—stomach cancer	6.71e-05	0.000212	CcSEcCtD
Moxifloxacin—Headache—Docetaxel—stomach cancer	6.71e-05	0.000212	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—stomach cancer	6.68e-05	0.000211	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—stomach cancer	6.68e-05	0.000211	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Methotrexate—stomach cancer	6.66e-05	0.00021	CcSEcCtD
Moxifloxacin—Fatigue—Methotrexate—stomach cancer	6.65e-05	0.00021	CcSEcCtD
Moxifloxacin—Pain—Methotrexate—stomach cancer	6.6e-05	0.000208	CcSEcCtD
Moxifloxacin—Vomiting—Capecitabine—stomach cancer	6.59e-05	0.000208	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.58e-05	0.000208	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—stomach cancer	6.57e-05	0.000208	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—stomach cancer	6.55e-05	0.000207	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—stomach cancer	6.54e-05	0.000207	CcSEcCtD
Moxifloxacin—Rash—Capecitabine—stomach cancer	6.53e-05	0.000206	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—stomach cancer	6.53e-05	0.000206	CcSEcCtD
Moxifloxacin—Dermatitis—Capecitabine—stomach cancer	6.53e-05	0.000206	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—stomach cancer	6.52e-05	0.000206	CcSEcCtD
Moxifloxacin—Headache—Capecitabine—stomach cancer	6.49e-05	0.000205	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—stomach cancer	6.49e-05	0.000205	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—stomach cancer	6.48e-05	0.000205	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—stomach cancer	6.46e-05	0.000204	CcSEcCtD
Moxifloxacin—Dyspnoea—Epirubicin—stomach cancer	6.44e-05	0.000203	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—stomach cancer	6.42e-05	0.000203	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—stomach cancer	6.37e-05	0.000201	CcSEcCtD
Moxifloxacin—Nausea—Docetaxel—stomach cancer	6.36e-05	0.000201	CcSEcCtD
Moxifloxacin—Feeling abnormal—Methotrexate—stomach cancer	6.36e-05	0.000201	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—stomach cancer	6.36e-05	0.000201	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Methotrexate—stomach cancer	6.31e-05	0.000199	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—stomach cancer	6.28e-05	0.000198	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—stomach cancer	6.24e-05	0.000197	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—stomach cancer	6.23e-05	0.000197	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—stomach cancer	6.22e-05	0.000197	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	6.19e-05	0.0312	CbGpPWpGaD
Moxifloxacin—Constipation—Epirubicin—stomach cancer	6.17e-05	0.000195	CcSEcCtD
Moxifloxacin—Pain—Epirubicin—stomach cancer	6.17e-05	0.000195	CcSEcCtD
Moxifloxacin—Nausea—Capecitabine—stomach cancer	6.16e-05	0.000195	CcSEcCtD
Moxifloxacin—Urticaria—Methotrexate—stomach cancer	6.13e-05	0.000194	CcSEcCtD
Moxifloxacin—Body temperature increased—Methotrexate—stomach cancer	6.1e-05	0.000193	CcSEcCtD
Moxifloxacin—Abdominal pain—Methotrexate—stomach cancer	6.1e-05	0.000193	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.09e-05	0.000192	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—stomach cancer	6.04e-05	0.000191	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—stomach cancer	6e-05	0.00019	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—stomach cancer	5.96e-05	0.000188	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—stomach cancer	5.95e-05	0.000188	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—stomach cancer	5.94e-05	0.000188	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—stomach cancer	5.9e-05	0.000187	CcSEcCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—APC—stomach cancer	5.89e-05	0.0297	CbGpPWpGaD
Moxifloxacin—Dyspepsia—Doxorubicin—stomach cancer	5.88e-05	0.000186	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—stomach cancer	5.81e-05	0.000183	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.77e-05	0.000182	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—stomach cancer	5.76e-05	0.000182	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—stomach cancer	5.74e-05	0.000181	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—stomach cancer	5.71e-05	0.000181	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—stomach cancer	5.71e-05	0.000181	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—stomach cancer	5.71e-05	0.00018	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—stomach cancer	5.71e-05	0.00018	CcSEcCtD
Moxifloxacin—Hypersensitivity—Methotrexate—stomach cancer	5.68e-05	0.00018	CcSEcCtD
Moxifloxacin—Asthenia—Methotrexate—stomach cancer	5.54e-05	0.000175	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—stomach cancer	5.51e-05	0.000174	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—stomach cancer	5.46e-05	0.000173	CcSEcCtD
Moxifloxacin—Pruritus—Methotrexate—stomach cancer	5.46e-05	0.000172	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—stomach cancer	5.32e-05	0.000168	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—stomach cancer	5.31e-05	0.000168	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—KMT2A—stomach cancer	5.29e-05	0.0267	CbGpPWpGaD
Moxifloxacin—Abdominal pain—Doxorubicin—stomach cancer	5.28e-05	0.000167	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—stomach cancer	5.28e-05	0.000167	CcSEcCtD
Moxifloxacin—Diarrhoea—Methotrexate—stomach cancer	5.28e-05	0.000167	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—stomach cancer	5.18e-05	0.000164	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—stomach cancer	5.11e-05	0.000161	CcSEcCtD
Moxifloxacin—Dizziness—Methotrexate—stomach cancer	5.1e-05	0.000161	CcSEcCtD
Moxifloxacin—Diarrhoea—Epirubicin—stomach cancer	4.94e-05	0.000156	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—stomach cancer	4.92e-05	0.000156	CcSEcCtD
Moxifloxacin—Vomiting—Methotrexate—stomach cancer	4.91e-05	0.000155	CcSEcCtD
Moxifloxacin—Rash—Methotrexate—stomach cancer	4.86e-05	0.000154	CcSEcCtD
Moxifloxacin—Dermatitis—Methotrexate—stomach cancer	4.86e-05	0.000154	CcSEcCtD
Moxifloxacin—Headache—Methotrexate—stomach cancer	4.83e-05	0.000153	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—stomach cancer	4.79e-05	0.000151	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—stomach cancer	4.77e-05	0.000151	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—stomach cancer	4.75e-05	0.024	CbGpPWpGaD
Moxifloxacin—Pruritus—Doxorubicin—stomach cancer	4.73e-05	0.000149	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—stomach cancer	4.59e-05	0.000145	CcSEcCtD
Moxifloxacin—Nausea—Methotrexate—stomach cancer	4.58e-05	0.000145	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—stomach cancer	4.57e-05	0.000144	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—stomach cancer	4.55e-05	0.000144	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—stomach cancer	4.55e-05	0.000144	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—stomach cancer	4.52e-05	0.000143	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—stomach cancer	4.42e-05	0.00014	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—stomach cancer	4.29e-05	0.000136	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—stomach cancer	4.25e-05	0.000134	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—stomach cancer	4.21e-05	0.000133	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—stomach cancer	4.21e-05	0.000133	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—stomach cancer	4.19e-05	0.000132	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	4.05e-05	0.0204	CbGpPWpGaD
Moxifloxacin—Nausea—Doxorubicin—stomach cancer	3.97e-05	0.000125	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	3.72e-05	0.0188	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	3.72e-05	0.0188	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—RORA—stomach cancer	3.49e-05	0.0176	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—stomach cancer	3.33e-05	0.0168	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	3.25e-05	0.0164	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—stomach cancer	3.25e-05	0.0164	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PRKAA1—stomach cancer	3.15e-05	0.0159	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—AHR—stomach cancer	3.12e-05	0.0157	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—stomach cancer	3.07e-05	0.0155	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—stomach cancer	3e-05	0.0152	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2D—stomach cancer	2.87e-05	0.0145	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	2.82e-05	0.0142	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	2.6e-05	0.0131	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—stomach cancer	2.57e-05	0.013	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2D—stomach cancer	2.57e-05	0.013	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	2.53e-05	0.0128	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—stomach cancer	2.52e-05	0.0127	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	2.41e-05	0.0122	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—stomach cancer	2.34e-05	0.0118	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	2.2e-05	0.0111	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	1.84e-05	0.00927	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—stomach cancer	1.83e-05	0.00922	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	1.81e-05	0.00912	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—AURKB—stomach cancer	1.8e-05	0.0091	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	1.78e-05	0.00896	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	1.76e-05	0.00887	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TYMS—stomach cancer	1.7e-05	0.0086	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	1.68e-05	0.00846	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	1.62e-05	0.00818	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—AURKB—stomach cancer	1.61e-05	0.00813	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—NPM1—stomach cancer	1.42e-05	0.00716	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—stomach cancer	1.4e-05	0.00705	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	1.38e-05	0.00698	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	1.35e-05	0.00679	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CDK4—stomach cancer	1.33e-05	0.0067	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	1.3e-05	0.00657	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—stomach cancer	1.24e-05	0.00624	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	1.21e-05	0.00612	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PPARG—stomach cancer	1.21e-05	0.00609	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—stomach cancer	1.18e-05	0.00595	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—stomach cancer	1.14e-05	0.00576	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	1.1e-05	0.00557	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—SERPINE1—stomach cancer	1.09e-05	0.00549	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—stomach cancer	1.04e-05	0.00522	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	1.01e-05	0.0051	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	9.89e-06	0.00499	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CHEK2—stomach cancer	9.53e-06	0.00481	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—stomach cancer	9.46e-06	0.00477	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	9.42e-06	0.00475	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	9.37e-06	0.00473	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—APEX1—stomach cancer	9.26e-06	0.00467	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	8.94e-06	0.00451	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	8.92e-06	0.0045	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	8.65e-06	0.00436	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—stomach cancer	8.59e-06	0.00434	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—JUN—stomach cancer	8.56e-06	0.00432	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	8.44e-06	0.00426	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PPP2R1A—stomach cancer	8.43e-06	0.00425	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—MAPK8—stomach cancer	8.1e-06	0.00409	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	7.79e-06	0.00393	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—stomach cancer	7.73e-06	0.0039	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TYMS—stomach cancer	7.68e-06	0.00388	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	7.37e-06	0.00372	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	7.17e-06	0.00362	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	7.01e-06	0.00354	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	7.01e-06	0.00354	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—BIRC5—stomach cancer	6.91e-06	0.00349	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—stomach cancer	6.7e-06	0.00338	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	6.68e-06	0.00337	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	6.63e-06	0.00334	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PRKCB—stomach cancer	6.59e-06	0.00333	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	6.09e-06	0.00307	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK4—stomach cancer	5.99e-06	0.00302	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PRKCB—stomach cancer	5.89e-06	0.00297	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	5.89e-06	0.00297	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—stomach cancer	5.65e-06	0.00285	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—IL6—stomach cancer	5.17e-06	0.00261	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—stomach cancer	5.12e-06	0.00258	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2A—stomach cancer	4.58e-06	0.00231	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—stomach cancer	4.54e-06	0.00229	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—stomach cancer	4.33e-06	0.00218	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—stomach cancer	4.19e-06	0.00211	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1B—stomach cancer	4.06e-06	0.00205	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—stomach cancer	3.87e-06	0.00195	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1A—stomach cancer	3.74e-06	0.00189	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—stomach cancer	3.57e-06	0.0018	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—stomach cancer	3.47e-06	0.00175	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—stomach cancer	3.4e-06	0.00171	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK3—stomach cancer	3.19e-06	0.00161	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYC—stomach cancer	3.1e-06	0.00157	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK1—stomach cancer	3.04e-06	0.00153	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TP53—stomach cancer	2.55e-06	0.00129	CbGpPWpGaD
